|
CrixivanDrug - Crixivan The trade name of the product as shown on the labeling.
Dosage -
CAPSULE; ORAL
Active Ingredient(s) -
Indinavir Sulfate
Strength -
EQ 333MG BASE
Applicant -
MERCK
New Drug Application (NDA) Number -
020685
Product Number -
005
Therapeutic Equivalence (TE) Code -
Approval Date -
Dec 17, 1998
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Merck Research Laboratories Div Merck Co Inc
Crixivan
Decabid Eq 100mg Base Tablet, Extended Release; Oral
Decabid Eq 50mg Base Tablet, Extended Release; Oral Decabid Eq 75mg Base Tablet, Extended Release; Oral Crixivan Eq 100mg Base Capsule; Oral Crixivan Eq 200mg Base Capsule; Oral Crixivan Eq 333mg Base Capsule; Oral Indapamide 1.25mg Tablet; Oral Indapamide 2.5mg Tablet; Oral Lozol 1.25mg Tablet; Oral Lozol 2.5mg Tablet; Oral NewDrugInformation |